Biotron Limited BITRF OTC

Other OTC • Healthcare • Biotechnology • AU • USD

SharesGrow Score

49/100

2/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Biotron Limited (BITRF) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 46/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score

49/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✓

HEALTH

100/100

Debt-to-Equity & liquidity

→ Health

MOAT

50/100

→ Income

✓

GROWTH

83/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — BITRF

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio17.71

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$-0.01	$1.55M	$-3M	-194.1%
2017	$-0.01	$1.66M	$-3.09M	-186.4%
2018	$0.00	$931.00	$-1.59M	-171175.6%
2019	$0.00	$1.07M	$-1.61M	-150.2%
2020	$-0.01	$50K	$-3.58M	-7151.9%
2021	$0.00	$1.46M	$-3.19M	-218.5%
2022	$0.00	$1.56M	$-2.78M	-178.4%
2023	$0.00	$1.43M	$-3.49M	-244%
2024	$0.00	$1.65M	$-3.44M	-208.9%
2025	$0.00	$1.81M	$-318.57K	-17.6%